Abstract
Due to increased life expectancy in a growing world population, the impact of ageing on the pathophysiology of cardiovascular diseases will increase. Therefore, a better understanding of agerelated biological changes is important and necessary to combat cardiovascular diseases in the future.
microRNAs (miRs) are small non coding RNAs emerging as key regulator in several vascular pathologies such as atherosclerosis or hypertension, which show a clear association with increasing age. This review discusses the involvement of miRs in several age-associated pathologies such as oxidative stress, vascular inflammation, vascular tension, endothelial cell senescence and impaired angiogenesis.
Current Vascular Pharmacology
Title:Role, Function and Therapeutic Potential of microRNAs in Vascular Aging
Volume: 13 Issue: 3
Author(s): Felix Jansen, Xiaoyan Yang, Georg Nickenig, Nikos Werner and Mariuca Vasa-Nicotera
Affiliation:
Keywords: microRNA, vascular, ageing.
Abstract: Due to increased life expectancy in a growing world population, the impact of ageing on the pathophysiology of cardiovascular diseases will increase. Therefore, a better understanding of agerelated biological changes is important and necessary to combat cardiovascular diseases in the future.
microRNAs (miRs) are small non coding RNAs emerging as key regulator in several vascular pathologies such as atherosclerosis or hypertension, which show a clear association with increasing age. This review discusses the involvement of miRs in several age-associated pathologies such as oxidative stress, vascular inflammation, vascular tension, endothelial cell senescence and impaired angiogenesis.
Export Options
About this article
Cite this article as:
Jansen Felix, Yang Xiaoyan, Nickenig Georg, Werner Nikos and Vasa-Nicotera Mariuca, Role, Function and Therapeutic Potential of microRNAs in Vascular Aging, Current Vascular Pharmacology 2015; 13 (3) . https://dx.doi.org/10.2174/15701611113119990129
DOI https://dx.doi.org/10.2174/15701611113119990129 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Naringin Inhibits TNF-α Induced Oxidative Stress and Inflammatory Response in HUVECs via Nox4/NF-κ B and PI3K/Akt Pathways
Current Pharmaceutical Biotechnology Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design Inflammatory Mechanisms and Redox Status in Periodontal and Cardiometabolic Diseases: Effects of Adjunctive Nutritional Antioxidants and Statins
Infectious Disorders - Drug Targets Editorial [Hot Topic:Modifying Cardiovascular Risk Factors: Newer Insights and Preventive Measures (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Plasma Potassium Levels in Healthy Prehypertension Subjects and the Role of A High Potassium Drink
Current Hypertension Reviews Preface
Cardiovascular & Hematological Agents in Medicinal Chemistry T-type Calcium Channels in Health and Disease
Current Medicinal Chemistry Anti-HER2 Therapy in Elderly Breast Cancer Patients
Reviews on Recent Clinical Trials Age-Related Changes in P-Glycoprotein Expression in Senescence- Accelerated Mouse
Current Aging Science Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
Current Drug Discovery Technologies Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews Ethiopathogenesis, Diagnosis and Prevention of Vascular Calcification in End Stage Renal Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases
Current Drug Targets Meet Our Editorial Board Member
Current Signal Transduction Therapy Beta-Blockers as First Line Treatment of Hypertension: A Proponents View
Current Hypertension Reviews Structure, Function and Biological Relevance of Prolyl Oligopeptidase
Current Protein & Peptide Science Pancreatic Cancer: Promises and Failures of Target Therapies
Reviews on Recent Clinical Trials Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm
Current Drug Targets